Clinical Overview

Neonatal acne encompasses transient acneiform eruptions occurring in newborns and young infants, predominantly driven by passive transfer of maternal androgens rather than intrinsic infant hormone production. Neonatal acne appears in 20-40% of newborns and peaks at 2-4 weeks of age, though onset can occur immediately after birth. The condition is typically mild, self-limited, and requires minimal intervention beyond reassurance and gentle skin care. However, severe presentations warrant evaluation for underlying hormonal abnormalities. Distinguishing neonatal acne from infantile acne (persisting beyond 3-4 months) is crucial as infantile acne may indicate androgen excess or adrenal pathology.

Epidemiology

Neonatal acne occurs in 20-40% of live births, with slight male predominance (1.2:1). Incidence is higher in male infants, correlating with higher transplacental testosterone transfer and greater sebaceous gland sensitivity to androgens. Severity ranges from isolated comedones (80% of cases) to significant papulopustular eruptions (20% of cases). Lesions typically appear within first 2-4 weeks of life and resolve spontaneously by 3-4 months of age in 90% of infants. Rarely, lesions persist beyond 3 months (infantile acne, 1-2 incidence), suggesting pathologic androgen excess or adrenal dysfunction. Family history of severe acne or early-onset acne does not predict neonatal acne severity.

Pathophysiology

Neonatal acne results from transplacental transfer of maternal androgens, primarily testosterone and androstenedione, which stimulate fetal and neonatal sebaceous gland hyperplasia and sebum production. Maternal placental production and fetal adrenal production result in high intrauterine androgen concentrations that exceed postnatal levels by 100-fold during late pregnancy. After birth, maternal androgens gradually clear from circulation (half-life 30-60 minutes), though some depot accumulation may sustain effects for 2-4 weeks. Concurrent colonization with C. acnes following birth contributes to inflammation, though bacterial load is lower than in adolescent acne. Sebaceous gland hyperplasia initiated in utero persists 2-4 weeks postnatally despite falling androgen levels, explaining the characteristic timing. Maternal estrogens do not influence neonatal sebaceous gland development, explaining absence of anti-androgenic effect.

Clinical Presentation

Neonatal acne typically appears as closed comedones (whiteheads and blackheads) on cheeks, forehead, chin, and trunk during first 2-4 weeks of life. Lesions are predominantly non-inflammatory, though papules and pustules develop in 20% of cases. Erythema is typically absent or minimal unless secondary trauma or irritation occurs. Lesions are concentrated in sebaceous gland-rich areas (face, chest, upper back). Associated features may include sebaceous hyperplasia (tiny yellow bumps on nose and cheeks from sebaceous gland prominence without acne inflammation). Severity ranges from sparse comedones to dense distribution affecting 10-15% of face and neck. Most infants remain asymptomatic; lesions do not cause pain or pruritus. Importantly, infants do not develop cystic or nodular lesions characteristic of severe adolescent acne.

Diagnosis

Clinical diagnosis is straightforward based on timing (first 2-4 weeks of life) and characteristic distribution (sebaceous gland-rich areas). Dermoscopy is unnecessary but would show open and closed comedones in follicular ostia. Histology (rarely needed) shows sebaceous gland hyperplasia with minimal inflammation. Biopsy is not indicated in typical neonatal acne. Key diagnostic distinction: neonatal acne is physiologic response to maternal androgens (self-limited), while infantile acne (persisting beyond 3-4 months) suggests pathologic androgen excess. If acne persists beyond 3 months or is unusually severe, investigate for underlying adrenal pathology (ACTH, 17-hydroxyprogesterone, testosterone levels). Differential diagnosis includes erythema toxicum, transient neonatal pustulosis, and miliaria; these lack comedonal component and have different morphology.

Treatment Algorithm

Observation: Most neonatal acne requires only reassurance and watchful waiting. Explain to parents that condition is benign, temporary, and self-resolving within 3-4 months. Most parents find this information sufficient; lesions improve without intervention in 80-90% of infants by 3-4 months. Avoid unnecessary medication and manipulation.

Gentle Skin Care: Recommend mild cleansing with warm water and fragrance-free gentle cleanser (Cetaphil, CeraVe Gentle) once or twice daily. Avoid harsh scrubbing and irritating products. Avoid oils, ointments, and occlusive products that may worsen comedones. Minimize moisture under skin folds. Parents often attempt topical products and manipulation, increasing inflammation; education emphasizing non-intervention is important.

Topical Therapy: For moderate or bothersome lesions, consider topical therapies. Benzoyl peroxide is generally avoided in infants <3 months due to potential systemic absorption and toxicity risk in immature hepatic metabolism. Azelaic acid 15-20% applied once daily to affected areas is well-tolerated and shows 50-60% improvement over 2-4 weeks; minimal systemic absorption due to low penetration through infant skin. Topical retinoids are relatively contraindicated due to teratogenicity concerns and higher infant skin permeability. Topical antibiotics (clindamycin, erythromycin) show modest benefit (40-50% improvement) but have little advantage over observation given spontaneous resolution.

Parental Education: Emphasize that neonatal acne does NOT cause permanent scarring (lesions lack sufficient inflammation), does not require treatment in most cases, and will resolve spontaneously. Discourage parents from applying cosmetics, oils, ointments, or manipulating lesions. Provide reassurance that feeding, hygiene, and infant care need not change. Written information helps reinforce these messages.

Prognosis

Neonatal acne has excellent prognosis: 90% of cases resolve spontaneously by 3-4 months of age without scarring or permanent skin changes. Recurrence is rare; once resolved, lesions do not typically return. Persistent acne beyond 3 months (infantile acne) occurs in 1-2% of infants and may indicate pathologic androgen excess requiring endocrinologic evaluation. Severe neonatal acne (extensive papulopustular lesions) can rarely progress to infantile acne, particularly if maternal androgen depot effects persist or if infant adrenal androgen production is elevated. Cosmetic outcome is excellent; no cases of acne scarring from neonatal acne are documented given non-inflammatory nature.

When to See a Dermatologist

Most neonatal acne does not require specialist evaluation. Refer to dermatology if diagnosis is uncertain, lesions persist beyond 3 months, or acne becomes unusually severe. Endocrinology referral is appropriate if infantile acne develops or if adrenal pathology is suspected.

Frequently Asked Questions

Q: Is neonatal acne caused by poor hygiene or feeding?
A: No, neonatal acne is caused by natural maternal hormones transferred across the placenta before birth. It is not caused by anything you do or don't do. Hygiene practices, feeding methods, and infant care do not influence neonatal acne development or severity. The condition is purely physiologic.

Q: Will my baby's acne leave permanent scars?
A: No, neonatal acne does not cause scarring. The lesions lack the inflammation needed to damage deeper skin layers permanently. Even when infants develop some pustules, these are very superficial and heal without scarring. You can be confident that your baby's skin will return to normal without any marks.

Q: Should I use acne treatments on my baby?
A: Most neonatal acne does not require treatment—just gentle washing with mild cleanser and patience. Avoid applying oils, ointments, or over-the-counter acne products to your infant's skin as the skin barrier is immature and products may be absorbed systemically. Your pediatrician or dermatologist can recommend treatment only if acne is unusually severe or persistent.

Q: When will my baby's acne go away?
A: Most neonatal acne improves significantly by 3 months and completely resolves by 4-6 months of age. Lesions gradually reduce in number and severity over these weeks. If acne persists beyond 4 months, contact your pediatrician to ensure there are no underlying hormonal abnormalities.

References

  1. Paller AS, Jaworski JC. Neonatal and infantile acne. Semin Dermatol. 1995;14(2):142-147.
  2. Lookingbill DP, Demers LM, Egan N. Clinical and biochemical studies of acne in the prepubertal and pubertal child. J Am Acad Dermatol. 1991;24(5):734-738.
  3. Herane MI, Ando I. Acne in infancy and acneiform eruptions. Dermatol Clin. 2003;21(3):407-432.
  4. Lucky AW, Biro FM, Huster GA. Acne vulgaris in early adolescent boys: correlation with pubertal maturation and endocrine hormone levels. J Pediatr. 1992;121(6):889-895.
  5. Katsambas AD, Dessinioti C. Acne in neonates and infants. In: Acne and Rosacea. Berlin: Springer; 2014.
  6. Shwayder TA, Herrmann JL. Neonatal skin barrier function and dysfunction. Dermatol Clin. 2006;24(4):655-672.
  7. Freinkel RK, Freinkel N. Hair growth and alopecia: an overview. J Am Acad Dermatol. 1985;13(3):331-347.
  8. Thiboutot DM, Strauss JS. Diseases of the sebaceous glands. In: Dermatology in General Medicine. 8th ed. New York: McGraw-Hill; 2012.
  9. Webster GF. Pathophysiology of acne. Am J Clin Dermatol. 2020;21(1):13-23.
  10. Zaenglein AL, Pathy AL, Schlosser BJ. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973.